Inogen (INGN) Competitors

AxoGen (NASDAQ:AXGN) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, dividends, media sentiment, risk and earnings.

Which has more risk & volatility, AXGN or INGN?

AxoGen has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500.

Do analysts recommend AXGN or INGN?

AxoGen presently has a consensus target price of $22.60, suggesting a potential upside of 31.93%. Inogen has a consensus target price of $7.00, suggesting a potential downside of 2.78%. Given AxoGen's stronger consensus rating and higher possible upside, research analysts clearly believe AxoGen is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inogen	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has stronger valuation & earnings, AXGN or INGN?

AxoGen has higher earnings, but lower revenue than Inogen. AxoGen is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$187.34M	4.05	-$21.72M	-$0.22	-77.86
Inogen	$335.71M	0.58	-$102.45M	-$1.52	-4.74

Does the media favor AXGN or INGN?

In the previous week, AxoGen had 4 more articles in the media than Inogen. MarketBeat recorded 6 mentions for AxoGen and 2 mentions for Inogen. AxoGen's average media sentiment score of 1.52 beat Inogen's score of 0.30 indicating that AxoGen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Inogen	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders believe in AXGN or INGN?

80.3% of AxoGen shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 7.0% of AxoGen shares are owned by company insiders. Comparatively, 1.5% of Inogen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community favor AXGN or INGN?

AxoGen received 68 more outperform votes than Inogen when rated by MarketBeat users. Likewise, 72.89% of users gave AxoGen an outperform vote while only 68.85% of users gave Inogen an outperform vote.

Company	Underperform	Outperform
AxoGen	Outperform Votes 457 72.89%	Underperform Votes 170 27.11%
Inogen	Outperform Votes 389 68.85%	Underperform Votes 176 31.15%

Is AXGN or INGN more profitable?

AxoGen has a net margin of -7.91% compared to Inogen's net margin of -15.89%. AxoGen's return on equity of -14.91% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-7.91%	-14.91%	-7.49%
Inogen	-15.89%	-27.38%	-16.77%

Summary

AxoGen beats Inogen on 14 of the 18 factors compared between the two stocks.